Learn more about our Global Affairs work.
WASHINGTON, D.C. – Since the onset of the coronavirus (COVID-19) outbreak, at least 31 AdvaMed® member companies have donated medical products worth approximately $26.8 million and made cash donations worth $4.1…
The objective of this study is to assess the potential impact of pricing regulation of medical devices in Brazil, China, Colombia and India.
WASHINGTON, D.C. – Scott Whitaker, President and CEO of the Advanced Medical Technology Association® (AdvaMed®), issued the following statement on the emergence of the coronavirus:
Contact: Jon [email protected] WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) issued the following statement from Ralph Ives, executive vice president, global strategy and analysis, following release of a…
A matrix of AdvaMed® regional priorities for Latin America (LatAm) by country.
The medical technology industry – led by AdvaMed® – is eager to continue discussions with India’s government toward effective solutions, to help the government achieve its stated health care goals…
This white paper seeks to investigate the impact of medical technology on Japan’s initiatives to promote healthy aging, increase workforce participation, and retain skilled labor.
Members of the Global Medical Technology Alliance (GMTA) support the objectives of providing safe, effective and innovative medical technology that saves and enhances lives, benefiting people and society.
AdvaMed® participated in and conducted a series of three international conferences to discuss and refine best practices for value-based procurement in the medical technology sector.